Litium: EBITDA beat bodes well for H2'23 - ABG
• ARR +8% y-o-y, in line with ABGSCe
• Cons. likely to make marginally pos. est. revisions
• Webcast scheduled for 11:00 CET
Q2'23 results
ARR SEK 72.4m (in line with ABGSCe 72.6m), net sales SEK 18.4m (+4% vs. ABGSCe 17.7m), EBITDA SEK 3.1m (vs. ABGSCe 1.8m), EBIT SEK -0.6m (vs. ABGSCe -1.4m), net profit SEK -0.7m (vs. ABGSCe -1.4m). With respect to ARR, the report was in line with expectations once again. The migration effect amounted to SEK -1.0m on ARR, meaning that an adjusted ARR would amount to SEK 73.4m. We are positively surprised by the company's beat on EBITDA, as the company benefited from operating cost declines of 7% while increasing sales by 10% y-o-y.
Länk till analysen i sin helhet: https://cr.abgsc.com/contentassets/f1ded144e65a4f3f82564c3953d42880/pdf/ebitda-beat-bodes-well-for-h223.pdf